[1] Munro MG, Critchley HOD, Fraser IS: The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 2018;143(3): 393-408.
[2] Whitaker L, Critchley HOD: Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2016;34: 54-65.
[3] Munro MG: Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations. Perm J 2014;18(1): 55-70.
[4] Valentine LN, Bradley LD: Hysteroscopy for Abnormal Uterine Bleeding and Fibroids. Clin Obstet Gynecol 2017;60(2): 231-244.
[5] Sinha P, Yadav N, Gupta U: Use of Hysteroscopy in Abnormal Uterine Bleeding: An Edge Over Histopathological Examination. J Obstet Gynaecol India 2018;68(1): 45-50.
[6] Vilos GA, AlJasser R, Vilos AG, Oraif A, Abduljabar H, Abu-Rafea B: Histopathology and Clinical Outcomes of 151 Women with Postmenopausal Bleeding Treated with Resectoscopic Surgery. J Minim Invasive Gynecol 2020;27(3): 763-773.
[7] Levy-Zauberman Y, Pourcelot AG, Capmas P, Fernandez H: Update on the management of abnormal uterine bleeding. J Gynecol Obstet Hum Reprod 2017;46(8): 613-622.
[8] Cholkeri-Singh A, Sasaki KJ: Hysteroscopy safety. Curr Opin Obstet Gynecol 2016;28(4): 250-254.
[9] Aas-Eng MK, Langebrekke A, Hudelist G: Complications in operative hysteroscopy - is prevention possible? Acta Obstet Gynecol Scand 2017;96(12): 1399-1403.
[10] Samy A, Raslan AN, Talaat B, El Lithy A, El Sharkawy M, Sharaf MF, et al.: Perioperative nonhormonal pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy: a systematic review and network meta-analysis. Fertil Steril 2020;113(1): 224-233.e226.
[11] Hoffman CR, Van Hal M, Tariq R, George S: Complications of fluid overload during hysteroscopic surgery. Korean J Anesthesiol 2019;72(4): 387-388.
[12] Kamath MS, Kalampokas EE, Kalampokas TE: Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014;177: 11-18.
[13] Lethaby A, Puscasiu L, Vollenhoven B: Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev 2017;11: Cd000547.
[14] Bizzarri N, Ghirardi V, Remorgida V, Venturini PL, Ferrero S: Three-month treatment with triptorelin, letrozole, and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. Eur J Obstet Gynecol Reprod Biol 2015;192: 22-26.
[15] Rasheedy R, Makled A, Abou-Gamrah A, Giuma H: Intrauterine Instillation of Tranexamic Acid in Hysteroscopic Myomectomy: A Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial. J Minim Invasive Gynecol 2019.
[16] Shokeir T, El-lakkany N, Sadek E, El-shamy M, Abu Hashim H: An RCT: Use of Oxytocin Drip during Hysteroscopic Endometrial Resection and Its Effect on Operative Blood Loss and Glycine Deficit. Journal of Minimally Invasive Gynecology 2011;18(4): 489-493.
[17] Yu D, Li T-C, Xia E, Huang X, Zheng J: A prospective randomized controlled trial on the effectiveness of routine Foley balloon tamponade on the reduction of bleeding after hysteroscopic resection of myoma. Gynecological Surgery 2006;3(2): 93.
[18] Cheng C, Zhao T, Xue M, Wan Y, Xu D: Use of suction curettage in operative hysteroscopy. J Minim Invasive Gynecol 2009;16(6): 739-742.
[19] Huchon C, Koskas M, Agostini A, Akladios C, Alouini S, Bauville E, et al.: Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial. Trials 2015;16: 363.
[20] Raimondo G, Raimondo D, D'Aniello G, Russo C, Ronga A, Gabbanini M, et al.: A randomized controlled study comparing carbon dioxide versus normal saline as distension media in diagnostic office hysteroscopy: is the distension with carbon dioxide a problem? Fertil Steril 2010;94(6): 2319-2322.
[21] Falcone F, Raimondo G, Stark M, Dessole S, Torella M, Raimondo I: Balloon Catheter for Cervical Priming before Operative Hysteroscopy in Young Women: A Pilot Study. J Invest Surg 2020;33(4): 301-306.
[22] Raimondo G, Grifone G, Raimondo D, Seracchioli R, Scambia G, Masciullo V: Hysteroscopic treatment of symptomatic cesarean-induced isthmocele: a prospective study. J Minim Invasive Gynecol 2015;22(2): 297-301.
[23] Indraccolo U, Bini V, Favilli A: Likelihood of Accomplishing an In-Patient Hysteroscopic Myomectomy in a One-Step Procedure: A Systematic Review and Meta-Analysis. BioMed Research International 2020;2020: 4208497.
[24] Yendru KS, Yelamanchi SD, Vaddiraju GB: Hysteroscopic Resection of Submucous Fibroids in Symptomatic Women. Journal of obstetrics and gynaecology of India 2019;69(2): 166-172.
[25] Lee MMH: Endometrial Polyp Removed by a Manual Hysteroscopic Tissue Removal Device. Gynecol Minim Invasive Ther 2020;9(1): 34-35.
[26] Murakami T, Tamura M, Ozawa Y, Suzuki H, Terada Y, Okamura K: Safe techniques in surgery for hysteroscopic myomectomy. Journal of Obstetrics and Gynaecology Research 2005;31(3): 216-223.
[27] Xu D, Jamail G, Xue M, Guan X, Wang L: Removal of Retained Adherent Placental Remnants Using Hysteroscopy Endo-Operative System (HEOS). Journal of Minimally Invasive Gynecology 2015;22(6): S137.